Gene: CYP26A1
Ensembl ID : ENSG00000095596
Description: cytochrome P450 family 26 subfamily A member 1
Gene Synonyms: CP26,CYP26,P450RAI,P450RAI1
1 APIs:
208 Possible Orthologues:

Cytochrome P450 - arranged by substrate type R-HSA-211897
Signaling by Nuclear Receptors R-HSA-9006931
RA biosynthesis pathway R-HSA-5365859
Vitamins R-HSA-211916
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Signal Transduction R-HSA-162582
Phase I - Functionalization of compounds R-HSA-211945
Signaling by Retinoic Acid R-HSA-5362517
Cytochrome P450 - arranged by substrate type R-HSA-211897
Vitamins R-HSA-211916
Phase I - Functionalization of compounds R-HSA-211945
RA biosynthesis pathway R-HSA-5365859
Metabolism R-HSA-1430728
Signaling by Nuclear Receptors R-HSA-9006931
Biological oxidations R-HSA-211859
Signal Transduction R-HSA-162582
Signaling by Retinoic Acid R-HSA-5362517
Biological oxidations R-HSA-211859
RA biosynthesis pathway R-HSA-5365859
Signaling by Retinoic Acid R-HSA-5362517
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Signal Transduction R-HSA-162582
Signaling by Nuclear Receptors R-HSA-9006931
Cytochrome P450 - arranged by substrate type R-HSA-211897
Vitamins R-HSA-211916
RA biosynthesis pathway R-HSA-5365859
Phase I - Functionalization of compounds R-HSA-211945
Vitamins R-HSA-211916
Biological oxidations R-HSA-211859
Signal Transduction R-HSA-162582
Signaling by Retinoic Acid R-HSA-5362517
Cytochrome P450 - arranged by substrate type R-HSA-211897
Signaling by Nuclear Receptors R-HSA-9006931
Metabolism R-HSA-1430728
RA biosynthesis pathway R-HSA-5365859
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Signal Transduction R-HSA-162582
Biological oxidations R-HSA-211859
Vitamins R-HSA-211916
Signaling by Retinoic Acid R-HSA-5362517
Signaling by Nuclear Receptors R-HSA-9006931
Signaling by Retinoic Acid R-HSA-5362517
Signal Transduction R-HSA-162582
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Vitamins R-HSA-211916
Phase I - Functionalization of compounds R-HSA-211945
RA biosynthesis pathway R-HSA-5365859
Signaling by Nuclear Receptors R-HSA-9006931
Metabolism R-HSA-1430728
Signaling by Retinoic Acid R-HSA-5362517
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Signal Transduction R-HSA-162582
Signaling by Nuclear Receptors R-HSA-9006931
Phase I - Functionalization of compounds R-HSA-211945
Vitamins R-HSA-211916
RA biosynthesis pathway R-HSA-5365859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Signaling by Nuclear Receptors R-HSA-9006931
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Signaling by Retinoic Acid R-HSA-5362517
Signal Transduction R-HSA-162582
Vitamins R-HSA-211916
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
RA biosynthesis pathway R-HSA-5365859
Signal Transduction R-HSA-162582
Signaling by Nuclear Receptors R-HSA-9006931
Metabolism R-HSA-1430728
Vitamins R-HSA-211916
RA biosynthesis pathway R-HSA-5365859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Signaling by Retinoic Acid R-HSA-5362517
Signal Transduction R-HSA-162582
Cytochrome P450 - arranged by substrate type R-HSA-211897
Signaling by Nuclear Receptors R-HSA-9006931
Signaling by Retinoic Acid R-HSA-5362517
Vitamins R-HSA-211916
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
RA biosynthesis pathway R-HSA-5365859

Expression Atlas ENSG00000095596
NCBI gene (formerly Entrezgene) 1592
GeneCards 2603
HGNC Symbol HGNC:2603
MIM gene 602239
UniProtKB Gene Name O43174
WikiGene 1592
Gene: CYP3A4
Ensembl ID : ENSG00000160868
Description: cytochrome P450 family 3 subfamily A member 4
Gene Synonyms: CYP3A3
3 APIs:
638 Possible Orthologues:

Xenobiotics R-HSA-211981
Biosynthesis of maresins R-HSA-9018682
Drug ADME R-HSA-9748784
Biological oxidations R-HSA-211859
Prednisone ADME R-HSA-9757110
Biosynthesis of maresin-like SPMs R-HSA-9027307
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Atorvastatin ADME R-HSA-9754706
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism of lipids R-HSA-556833
Aspirin ADME R-HSA-9749641
Biosynthesis of maresin-like SPMs R-HSA-9027307
Phase I - Functionalization of compounds R-HSA-211945
Metabolism of lipids R-HSA-556833
Drug ADME R-HSA-9748784
Atorvastatin ADME R-HSA-9754706
Biological oxidations R-HSA-211859
Aflatoxin activation and detoxification R-HSA-5423646
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Aspirin ADME R-HSA-9749641
Biosynthesis of maresins R-HSA-9018682
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Prednisone ADME R-HSA-9757110
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Biosynthesis of maresin-like SPMs R-HSA-9027307
Biosynthesis of maresins R-HSA-9018682
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Drug ADME R-HSA-9748784
Aflatoxin activation and detoxification R-HSA-5423646
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Phase I - Functionalization of compounds R-HSA-211945
Aspirin ADME R-HSA-9749641
Prednisone ADME R-HSA-9757110
Metabolism of lipids R-HSA-556833
Biological oxidations R-HSA-211859
Atorvastatin ADME R-HSA-9754706
Cytochrome P450 - arranged by substrate type R-HSA-211897
Phase I - Functionalization of compounds R-HSA-211945
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism of lipids R-HSA-556833
Prednisone ADME R-HSA-9757110
Metabolism R-HSA-1430728
Atorvastatin ADME R-HSA-9754706
Drug ADME R-HSA-9748784
Biological oxidations R-HSA-211859
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Biosynthesis of maresin-like SPMs R-HSA-9027307
Biosynthesis of maresins R-HSA-9018682
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Aspirin ADME R-HSA-9749641
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Aflatoxin activation and detoxification R-HSA-5423646
Drug ADME R-HSA-9748784
Aspirin ADME R-HSA-9749641
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Cytochrome P450 - arranged by substrate type R-HSA-211897
Atorvastatin ADME R-HSA-9754706
Biosynthesis of maresins R-HSA-9018682
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Biosynthesis of maresin-like SPMs R-HSA-9027307
Metabolism of lipids R-HSA-556833
Xenobiotics R-HSA-211981
Prednisone ADME R-HSA-9757110
Metabolism of lipids R-HSA-556833
Biological oxidations R-HSA-211859
Aflatoxin activation and detoxification R-HSA-5423646
Cytochrome P450 - arranged by substrate type R-HSA-211897
Drug ADME R-HSA-9748784
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Biosynthesis of maresins R-HSA-9018682
Xenobiotics R-HSA-211981
Aspirin ADME R-HSA-9749641
Phase I - Functionalization of compounds R-HSA-211945
Biosynthesis of maresin-like SPMs R-HSA-9027307
Prednisone ADME R-HSA-9757110
Metabolism R-HSA-1430728
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Atorvastatin ADME R-HSA-9754706
Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Biosynthesis of maresins R-HSA-9018682
Biological oxidations R-HSA-211859
Atorvastatin ADME R-HSA-9754706
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Aspirin ADME R-HSA-9749641
Aflatoxin activation and detoxification R-HSA-5423646
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Metabolism of lipids R-HSA-556833
Drug ADME R-HSA-9748784
Biosynthesis of maresin-like SPMs R-HSA-9027307
Prednisone ADME R-HSA-9757110
Aspirin ADME R-HSA-9749641
Phase I - Functionalization of compounds R-HSA-211945
Biosynthesis of maresin-like SPMs R-HSA-9027307
Drug ADME R-HSA-9748784
Metabolism of lipids R-HSA-556833
Xenobiotics R-HSA-211981
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Biosynthesis of maresins R-HSA-9018682
Biological oxidations R-HSA-211859
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Atorvastatin ADME R-HSA-9754706
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Prednisone ADME R-HSA-9757110
Atorvastatin ADME R-HSA-9754706
Biosynthesis of maresins R-HSA-9018682
Aspirin ADME R-HSA-9749641
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Biosynthesis of DHA-derived SPMs R-HSA-9018677
Metabolism R-HSA-1430728
Metabolism of lipids R-HSA-556833
Biosynthesis of maresin-like SPMs R-HSA-9027307
Cytochrome P450 - arranged by substrate type R-HSA-211897
Drug ADME R-HSA-9748784
Prednisone ADME R-HSA-9757110
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678
Phase I - Functionalization of compounds R-HSA-211945

Expression Atlas ENSG00000160868
NCBI gene (formerly Entrezgene) 1576
GeneCards 2637
HGNC Symbol HGNC:2637
MIM gene 124010
MIM morbid 619073
UniProtKB Gene Name Q6GRK0
WikiGene 1576
Gene: CYP3A43
Ensembl ID : ENSG00000021461
Description: cytochrome P450 family 3 subfamily A member 43
Gene Synonyms:
2 APIs:
652 Possible Orthologues:

Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Metabolism R-HSA-1430728
Miscellaneous substrates R-HSA-211958
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Miscellaneous substrates R-HSA-211958
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Miscellaneous substrates R-HSA-211958
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Miscellaneous substrates R-HSA-211958
Metabolism R-HSA-1430728
Miscellaneous substrates R-HSA-211958
Xenobiotics R-HSA-211981
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Miscellaneous substrates R-HSA-211958
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Miscellaneous substrates R-HSA-211958
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Miscellaneous substrates R-HSA-211958
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Miscellaneous substrates R-HSA-211958
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728

Expression Atlas ENSG00000021461
NCBI gene (formerly Entrezgene) 64816
GeneCards 17450
HGNC Symbol HGNC:17450
MIM gene 606534
UniProtKB Gene Name Q9HB55
WikiGene 64816
Gene: CYP3A7
Ensembl ID : ENSG00000160870
Description: cytochrome P450 family 3 subfamily A member 7
Gene Synonyms: CP37,P450-HFLA
2 APIs:
646 Possible Orthologues:

Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Xenobiotics R-HSA-211981
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Xenobiotics R-HSA-211981
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728

Expression Atlas ENSG00000160870
NCBI gene (formerly Entrezgene) 1551
GeneCards 2640
HGNC Symbol HGNC:2640
MIM gene 605340
UniProtKB Gene Name P24462
WikiGene 1551
Gene: CYP3A5
Ensembl ID : ENSG00000106258
Description: cytochrome P450 family 3 subfamily A member 5
Gene Synonyms: CP35,P450PCN3,PCN3
2 APIs:
643 Possible Orthologues:

Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Aflatoxin activation and detoxification R-HSA-5423646
Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Aflatoxin activation and detoxification R-HSA-5423646
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897

Expression Atlas ENSG00000106258
LRG display in Ensembl gene LRG_1431
NCBI gene (formerly Entrezgene) 1577
GeneCards 2638
HGNC Symbol HGNC:2638
MIM gene 605325
MIM morbid 145500
UniProtKB Gene Name Q7Z3N0
WikiGene 1577
Gene: CYP3A7
Ensembl ID : ENSG00000160870
Description: cytochrome P450 family 3 subfamily A member 7
Gene Synonyms: CP37,P450-HFLA
2 APIs:
646 Possible Orthologues:

Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Xenobiotics R-HSA-211981
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Xenobiotics R-HSA-211981
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728

Expression Atlas ENSG00000160870
NCBI gene (formerly Entrezgene) 1551
GeneCards 2640
HGNC Symbol HGNC:2640
MIM gene 605340
UniProtKB Gene Name P24462
WikiGene 1551
Gene: CYP3A43
Ensembl ID : ENSG00000021461
Description: cytochrome P450 family 3 subfamily A member 43
Gene Synonyms:
2 APIs:
652 Possible Orthologues:

Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Metabolism R-HSA-1430728
Miscellaneous substrates R-HSA-211958
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Miscellaneous substrates R-HSA-211958
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Miscellaneous substrates R-HSA-211958
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Miscellaneous substrates R-HSA-211958
Metabolism R-HSA-1430728
Miscellaneous substrates R-HSA-211958
Xenobiotics R-HSA-211981
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Miscellaneous substrates R-HSA-211958
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Miscellaneous substrates R-HSA-211958
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Miscellaneous substrates R-HSA-211958
Metabolism R-HSA-1430728
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Miscellaneous substrates R-HSA-211958
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Metabolism R-HSA-1430728

Expression Atlas ENSG00000021461
NCBI gene (formerly Entrezgene) 64816
GeneCards 17450
HGNC Symbol HGNC:17450
MIM gene 606534
UniProtKB Gene Name Q9HB55
WikiGene 64816
Gene: CYP3A5
Ensembl ID : ENSG00000106258
Description: cytochrome P450 family 3 subfamily A member 5
Gene Synonyms: CP35,P450PCN3,PCN3
2 APIs:
643 Possible Orthologues:

Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Aflatoxin activation and detoxification R-HSA-5423646
Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Aflatoxin activation and detoxification R-HSA-5423646
Biological oxidations R-HSA-211859
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Biological oxidations R-HSA-211859
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Cytochrome P450 - arranged by substrate type R-HSA-211897
Metabolism R-HSA-1430728
Biological oxidations R-HSA-211859
Xenobiotics R-HSA-211981
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897
Phase I - Functionalization of compounds R-HSA-211945
Xenobiotics R-HSA-211981
Phase I - Functionalization of compounds R-HSA-211945
Biological oxidations R-HSA-211859
Aflatoxin activation and detoxification R-HSA-5423646
Metabolism R-HSA-1430728
Cytochrome P450 - arranged by substrate type R-HSA-211897

Expression Atlas ENSG00000106258
LRG display in Ensembl gene LRG_1431
NCBI gene (formerly Entrezgene) 1577
GeneCards 2638
HGNC Symbol HGNC:2638
MIM gene 605325
MIM morbid 145500
UniProtKB Gene Name Q7Z3N0
WikiGene 1577